From Molecule to Dose Form – Accelerated Bioavailability Enhancement for Early Phase Molecules
Summary: During the early stages of drug development process (i.e. preclinical to Phase I), scientists are often faced with a set of challenges to deliver against the Target Product Profile, with the top three being bioavailability, stability, and delivery profile. A viable bioavailability enhancement toolkit already exists. However, to accelerate development and discharge risk at an early phase, it is essential to examine and rank multiple delivery options in parallel. This approach optimizes the performance of the drug candidates advanced through early preclinical and clinical studies.
This 60-minute webinar will provide an overview of a structured approach with parallel formulation feasibility assessment that is designed to reveal the most suitable pathway to enhance bioavailability and accelerate development.